341 related articles for article (PubMed ID: 24187403)
1. Renal elimination of sclerostin increases with declining kidney function.
Cejka D; Marculescu R; Kozakowski N; Plischke M; Reiter T; Gessl A; Haas M
J Clin Endocrinol Metab; 2014 Jan; 99(1):248-55. PubMed ID: 24187403
[TBL] [Abstract][Full Text] [Related]
2. Sclerostin: Another vascular calcification inhibitor?
Claes KJ; Viaene L; Heye S; Meijers B; d'Haese P; Evenepoel P
J Clin Endocrinol Metab; 2013 Aug; 98(8):3221-8. PubMed ID: 23788689
[TBL] [Abstract][Full Text] [Related]
3. Serum sclerostin and adverse outcomes in nondialyzed chronic kidney disease patients.
Kanbay M; Siriopol D; Saglam M; Kurt YG; Gok M; Cetinkaya H; Karaman M; Unal HU; Oguz Y; Sari S; Eyileten T; Goldsmith D; Vural A; Veisa G; Covic A; Yilmaz MI
J Clin Endocrinol Metab; 2014 Oct; 99(10):E1854-61. PubMed ID: 25057883
[TBL] [Abstract][Full Text] [Related]
4. The relation between renal function and serum sclerostin in adult patients with CKD.
Pelletier S; Dubourg L; Carlier MC; Hadj-Aissa A; Fouque D
Clin J Am Soc Nephrol; 2013 May; 8(5):819-23. PubMed ID: 23430206
[TBL] [Abstract][Full Text] [Related]
5. Serum sclerostin as a potential novel biomarker for heart valve calcification in patients with chronic kidney disease.
Ji YQ; Guan LN; Yu SX; Yin PY; Shen XQ; Sun ZW; Liu J; Lv W; Yu GP; Ren C
Eur Rev Med Pharmacol Sci; 2018 Dec; 22(24):8822-8829. PubMed ID: 30575924
[TBL] [Abstract][Full Text] [Related]
6. Osteoprotegerin and sclerostin in chronic kidney disease prior to dialysis: potential partners in vascular calcifications.
Morena M; Jaussent I; Dupuy AM; Bargnoux AS; Kuster N; Chenine L; Leray-Moragues H; Klouche K; Vernhet H; Canaud B; Cristol JP
Nephrol Dial Transplant; 2015 Aug; 30(8):1345-56. PubMed ID: 25854266
[TBL] [Abstract][Full Text] [Related]
7. [Role of the morphogenetic proteins FGF-23 and Klotho and the glycoprotein sclerostin in the assessment of the risk of cardiovascular diseases and the prognosis of chronic kidney disease].
Milovanova LY; Milovanov YS; Kudryavtseva DV; Markina MM; Milovanova SY; Kozlovskaya LV; Lebedeva MV; Beketov VD; Moiseev SV; Mukhin NA; Fomin VV; Svistunov AA
Ter Arkh; 2015; 87(6):10-16. PubMed ID: 26281189
[TBL] [Abstract][Full Text] [Related]
8. Active vitamin D treatment in CKD patients raises serum sclerostin and this effect is modified by circulating pentosidine levels.
Torino C; Pizzini P; Cutrupi S; Tripepi G; Mallamaci F; Thadhani R; Zoccali C
Nutr Metab Cardiovasc Dis; 2017 Mar; 27(3):260-266. PubMed ID: 28017524
[TBL] [Abstract][Full Text] [Related]
9. Estimated glomerular filtration rate variability and risk of end-stage renal disease among patients with Stage 3 chronic kidney disease.
Perkins RM; Kirchner HL; Hartle JE; Bucaloiu ID
Clin Nephrol; 2013 Oct; 80(4):256-62. PubMed ID: 23993165
[TBL] [Abstract][Full Text] [Related]
10. Serum level of fibroblast growth factor 23 in maintenance renal transplant patients.
Sánchez Fructuoso AI; Maestro ML; Pérez-Flores I; Valero R; Rafael S; Veganzones S; Calvo N; De la Orden V; De la Flor JC; Valga F; Vidaurreta M; Fernández-Pérez C; Barrientos A
Nephrol Dial Transplant; 2012 Nov; 27(11):4227-35. PubMed ID: 23144073
[TBL] [Abstract][Full Text] [Related]
11. The Association of Urinary Sclerostin and Renal Magnesium Handling in Type 2 Diabetic Patients with Chronic Kidney Disease.
Wu CF; Liou HH; Kuo CC; Tsai MH; Chang MY; Lee YC; Lin TM; Hung SY
Kidney Blood Press Res; 2021; 46(4):514-522. PubMed ID: 34134118
[TBL] [Abstract][Full Text] [Related]
12. Sclerostin blood levels before and after kidney transplantation.
Bonani M; Rodriguez D; Fehr T; Mohebbi N; Brockmann J; Blum M; Graf N; Frey D; Wüthrich RP
Kidney Blood Press Res; 2014; 39(4):230-9. PubMed ID: 25118597
[TBL] [Abstract][Full Text] [Related]
13. Validation of some pathophysiological mechanisms of the CKD progression theory and outcome prediction in IgA nephropathy.
Bazzi C; Rizza V; Casellato D; Stivali G; Rachele G; Napodano P; Olivieri G; Gallieni M; D'Amico G
J Nephrol; 2012; 25(5):810-8. PubMed ID: 22252844
[TBL] [Abstract][Full Text] [Related]
14. Uremic toxicity and sclerostin in chronic kidney disease patients.
Desjardins L; Liabeuf S; Oliveira RB; Louvet L; Kamel S; Lemke HD; Vanholder R; Choukroun G; Massy ZA;
Nephrol Ther; 2014 Nov; 10(6):463-70. PubMed ID: 25070604
[TBL] [Abstract][Full Text] [Related]
15. Circulating sclerostin and Dickkopf-1 (DKK1) in predialysis chronic kidney disease (CKD): relationship with bone density and arterial stiffness.
Thambiah S; Roplekar R; Manghat P; Fogelman I; Fraser WD; Goldsmith D; Hampson G
Calcif Tissue Int; 2012 Jun; 90(6):473-80. PubMed ID: 22527202
[TBL] [Abstract][Full Text] [Related]
16. Secreted Klotho and FGF23 in chronic kidney disease Stage 1 to 5: a sequence suggested from a cross-sectional study.
Pavik I; Jaeger P; Ebner L; Wagner CA; Petzold K; Spichtig D; Poster D; Wüthrich RP; Russmann S; Serra AL
Nephrol Dial Transplant; 2013 Feb; 28(2):352-9. PubMed ID: 23129826
[TBL] [Abstract][Full Text] [Related]
17. Renal Handling of Sclerostin in Response to Acute Glomerular Filtration Decline.
Kakareko K; Rydzewska-Rosolowska A; Brzosko S; Gozdzikiewicz-Lapinska J; Koc-Zorawska E; Samocik P; Kozlowski R; Mysliwiec M; Naumnik B; Hryszko T
Horm Metab Res; 2016 Jul; 48(7):457-61. PubMed ID: 27214309
[TBL] [Abstract][Full Text] [Related]
18. Exercise Alleviates Osteoporosis in Rats with Mild Chronic Kidney Disease by Decreasing Sclerostin Production.
Liao HW; Huang TH; Chang YH; Liou HH; Chou YH; Sue YM; Hung PH; Chang YT; Ho PC; Tsai KJ
Int J Mol Sci; 2019 Apr; 20(8):. PubMed ID: 31027235
[TBL] [Abstract][Full Text] [Related]
19. Impact of routine reporting of estimated glomerular filtration rate using the CKD-EPI formula in a community population: A cross-sectional cohort study.
Mitchell T; Hadlow N; Chakera A
Nephrology (Carlton); 2014 Sep; 19(9):581-6. PubMed ID: 24888643
[TBL] [Abstract][Full Text] [Related]
20. Bone and mineral metabolism and fibroblast growth factor 23 levels after kidney donation.
Young A; Hodsman AB; Boudville N; Geddes C; Gill J; Goltzman D; Jassal SV; Klarenbach S; Knoll G; Muirhead N; Prasad GV; Treleaven D; Garg AX;
Am J Kidney Dis; 2012 Jun; 59(6):761-9. PubMed ID: 22093959
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
